v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows provided by/(used in) operating activities:    
Net increase/(decrease) in net assets resulting from operations $ 3,109 $ 2,891
Adjustments to reconcile net increase/(decrease) in net assets resulting from operation to net cash provided by/(used in) operating activities:    
Net change in unrealized appreciation/(depreciation) from investments (55) (319)
Net realized gain/(loss) from investments (16) (290)
Accretion of original issue discounts and end of term payments on investments (1,534) (613)
Amortization of deferred financing costs 222 214
Purchases of investments, net of deferred fees (28,207) (23,077)
Interest received in-kind (38) (38)
Proceeds from the sale and paydowns of investments 13,004 8,355
Change in operating assets and liabilities    
(Increase)/Decrease in due from affiliates 1,271 0
Increase/(Decrease) in interest receivable and other assets (132) (20)
Increase/(Decrease) in security deposits (21) 5
Increase/(Decrease) in directors fees payable 275 0
Increase/(Decrease) in accrued expenses and other liabilities 180 103
Increase/(Decrease) in management fees payable, incentive fees payable, and interest payable 576 155
Net cash provided by/(used in) operating activities (11,366) (12,634)
Cash flows provided by/(used in) financing activities    
Capital contributions 909 0
Distributions (3,051) 0
Borrowings under Credit Facility 35,300 16,700
Repayments under Credit Facility (19,400) (5,500)
Deferred credit facility costs paid (415) 0
Net cash provided by/(used in) financing activities 13,343 11,200
Net increase/(decrease) in cash and cash equivalents 1,977 (1,434)
Cash and cash equivalents at beginning of period 576 2,239
Cash and cash equivalents at end of period 2,553 805
Supplemental and non-cash financing activities:    
Cash paid during the period for interest $ 2,326 $ 536